Rheumatology International

Papers
(The median citation count of Rheumatology International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review58
Cardiac involvement in primary Sjӧgren’s syndrome55
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed54
Epidemiology and genetics of granulomatosis with polyangiitis53
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis51
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study43
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR43
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases38
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study35
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study32
Assessment of sarcopenia in patients with fibromyalgia26
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic26
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review25
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201723
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination22
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis21
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes21
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development20
Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study20
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients20
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey19
The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis19
Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience18
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study17
Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review16
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study16
The stratification of primary Sjogren’s syndrome: is it really solving the problem?16
Reactive arthritis after COVID-19: a case-based review15
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient15
Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study15
The efficacy and safety of extracorporeal shock wave therapy on plantar fasciitis in patients with axial spondyloarthritis: a double-blind, randomized controlled trial13
The continuum of art and rheumatology: a discernment of mutual inclusivity13
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study12
The impact of the COVID-19 pandemic on patients with primary Sjögren syndrome11
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice11
Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis11
Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review11
The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey10
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases10
Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis10
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study9
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study9
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials9
The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study8
Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey8
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls8
0.13537883758545